Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jaroslaw, Cisowski"'
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-19 (2023)
Abstract Hepatocellular carcinoma and intrahepatic cholangiocarcinoma are devastating primary liver cancers with increasing prevalence in many parts of the world. Despite intense investigation, many aspects of their biology are still largely obscure.
Externí odkaz:
https://doaj.org/article/e59b2d2697c644ed8accd742163dcd89
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/b770873405b346a2b9474ba257b48a29
Autor:
Mohamed X. Ibrahim, Anna Staffas, Volkan I. Sayin, Per Lindahl, Christin Karlsson, Murali K. Akula, Martin O. Bergo, Jaroslaw Cisowski
Publikováno v:
Leukemia. 35:606-609
Autor:
Christin, Karlsson, Murali K, Akula, Anna, Staffas, Jaroslaw, Cisowski, Volkan I, Sayin, Mohamed X, Ibrahim, Per, Lindahl, Martin O, Bergo
Publikováno v:
Leukemia. 35(2)
Autor:
Jaroslaw Cisowski, Martin O. Bergo
Publikováno v:
Small GTPases. 8:187-192
Cancer is driven by mutations in genes whose products participate in major signaling pathways that fuel cell proliferation and survival. It is easy to assume that the more of these so-called driver mutations a tumor accumulates, the faster it progres
Publikováno v:
Oncogene. 35:1328-1333
KRAS and BRAF are among the most commonly mutated oncogenes in human cancer that contribute to tumorigenesis in both distinct and overlapping tissues. However, KRAS and BRAF mutations are mutually exclusive; they never occur in the same tumor cell. T
Autor:
Urszula Florczyk, Jozef Dulak, Slawomir Golda, Agata Zieba, Jaroslaw Cisowski, Alicja Jozkowicz
Publikováno v:
Cancer letters. 300(1)
Biliverdin reductase (BVR) converts biliverdin to bilirubin. Additionally, acting as a transcription factor and possessing a capacity of a serine/threonine kinase, it may modulate signaling pathways. In order to gain better understanding of BVR funct
Autor:
Jaroslaw Cisowski, Jozef Dulak, Alicja Jozkowicz, Halina Was, Jerzy Kotlinowski, Guenter Weigel, Katarzyna Mleczko, Hevidar Taha
Publikováno v:
Antioxidantsredox signaling. 10(12)
15-Deoxy-Delta(12,14)-prostaglandin-J(2) (15d-PGJ(2)) is a cyclopentenone prostaglandin regarded as antiinflammatory mediator, which can act through peroxisome proliferator-activated receptor-gamma (PPARgamma) or through G protein-coupled surface rec
Autor:
Agnieszka Loboda, Andrzej J. Rutkowski, Anna Grochot-Przeczek, Agnieszka Jazwa, Alicja Jozkowicz, Jozef Dulak, Anupam Agarwal, Jaroslaw Cisowski
Heme oxygenase-1, an enzyme degrading heme to carbon monoxide, iron, and biliverdin, has been recognized as playing a crucial role in cellular defense against stressful conditions, not only related to heme release. HO-1 protects endothelial cells fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d419129320f83154b4d6afe4c6cf1fb
https://ruj.uj.edu.pl/xmlui/handle/item/76404
https://ruj.uj.edu.pl/xmlui/handle/item/76404
Autor:
Alicja Jozkowicz, Jozef Dulak, Agnieszka Loboda, Justyna Drukala, Agnieszka Jazwa, Magdalena Szelag, Jaroslaw Cisowski, Slawomir Golda, Anna Zagorska, Patrycja Sroczynska
Background Skin injury leads to the release of heme, a potent prooxidant which is degraded by heme oxygenase-1 (HO-1) to carbon monoxide, iron, and biliverdin, subsequently reduced to bilirubin. Recently the involvement of HO-1 in angiogenesis has be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a95f9e57483a89f4b42f2a10a27c50
https://europepmc.org/articles/PMC1414644/
https://europepmc.org/articles/PMC1414644/